metabolic disorder

(redirected from Metabolic disorders)
Also found in: Dictionary, Thesaurus, Medical.
Related to Metabolic disorders: metabolic syndrome

metabolic disorder

[‚med·ə′bäl·ik dis′ȯrd·ər]
(medicine)
Any disorder that involves an alteration in the normal metabolism of carbohydrates, lipids, proteins, water, and nucleic acids; evidenced by various syndromes and diseases.
References in periodicals archive ?
A review of the Other Metabolic disorders products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
The most likely explanation is that these children died as a consequence of a metabolic disorder.
Pipeline gene therapy products under metabolic disorders, gene therapy products distribution on the basis of delivery system developed and on the basis of genetic material transfer techniques are covered along with gene therapies profiles.
Based on increasing trends in reported prevalence and the potential for environmental exposures to increase population risks, consideration should also be given to developmental disabilities, reproductive disorders, and endocrine and metabolic disorders.
Global Markets Direct's, 'Inherited Metabolic Disorders - Pipeline Review, H2 2012', provides an overview of the Inherited Metabolic Disorders therapeutic pipeline.
This clinical trial report, Inherited Metabolic Disorders Global Clinical Trials Review, H2, 2012" provides data on the Inherited Metabolic Disorders clinical trial scenario.
CNS disorders accounted for 14% of early stage drugs under development, followed by immunological disorders (13%) and metabolic disorders (10%).
GlobalData's clinical trial report, Other Metabolic Disorders Global Clinical Trials Review, H1, 2012" provides data on the Other Metabolic Disorders clinical trial scenario.
GBI Research, the leading business intelligence provider, has released its latest research, Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value, which provides insights into metabolic disease therapeutics until 2017.
KING OF PRUSSIA, PA, July 19 /PRNewswire-FirstCall/ -- MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, has launched a new therapeutic focus on metabolic disorders such as diabetes, dyslipidemia, obesity and metabolic syndrome - a cluster of conditions that damage the cardiovascular system.